Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity

American Journal of Pathology

Volumn 158, Issue 1, 2001, Pages 247-257

  Aguirre, José ^a   Buttery, Lee D K ^a   O'Shaughnessy, Meg ^a   Afzal, Faiza ^a   Fernandez de Marticorena, Iñigo ^a   Hukkanen, Mika ^a   Huang, Paul ^b   MacIntyre, Iain ^c   Polak, Julia ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; CELL ACTIVITY; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ENZYME DEFICIENCY; KNOCKOUT MOUSE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL;

EID: 0035139484     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63963-6     Document Type: Article

References (54)

1. Polypeptide factors regulating osteogenesis and bone marrow repair
2. Osteonal and hemi-osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone
3. The L-arginine-nitric oxide pathway
4. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme
5. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells
6. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
7. Nitric oxide: Pathophysiological mechanisms
8. Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms
9. Bone cell function, regulation, and communication: A role for nitric oxide
10. Expression of nitric oxide synthase isoforms in bone and bone cell cultures
11. Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase
12. Nitric oxide: A cytokine-induced regulator of bone resorption
13. Osteoclastic inhibition: An action of nitric oxide not mediated by cyclic GMP
14. Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: Autocrine NO mediates Ca2+-inhibited bone resorption
15. Mechanisms of cytokine induced bone resorption: Role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins
16. Expression and functional role of nitric oxide synthase in osteoblast-like cells
17. Nitric oxide donor alleviates ovariectomy-induced bone loss
18. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells
19. Mechanical strain-induced NO production by bone cells: A possible role in adaptive bone (re)modeling?
20. Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation
21. Nitric oxide inhibitor L-NAME suppresses mechanically induced bone formation in rats
22. Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes
23. Nitric oxide response to shear stress by human bone cell cultures is endothelial nitric oxide synthase dependent
24. TI: Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase
25. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption
26. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity
27. Effect of nitric oxide synthase inhibitors on bone metabolism in growing rats
28. Effects of nitric oxide synthase inhibitors on bone formation in rats
29. Hypertension in mice lacking the gene for endothelial nitric oxide synthase
30. Bone cell kinetics during longitudinal bone growth in the rat
31. Bone histomorphometry: Proposed system for standardization of nomenclature, symbols and units
32. Separation of parathyroid hormone and calcitonin sensitive cells from non-responsive bone cells
33. Chemotactic response of osteoblast-like cells to TGF-β
34. Nitric oxide synthase inhibitors. Septic shock methods and protocols
35. Formation of mineralised nodules by bone derived cells in vitro: A model of bone formation?
36. The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent
37. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II
38. Role of endothelial nitric oxide synthase in endothelial cell migration
39. Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling
40. Control of cytoskeletal mechanisms by extracellular matrix, cell shape and mechanical tension
41. Developmental regulation of nitric oxide synthase expression in rat skeletal bone
42. Limb reduction defects in endothelial nitric oxide synthase-deficient mice
43. Dissociation between bone resorption and bone formation in osteopenic transgenic mice
44. Studies in the inducible nitric oxide synthase knockout mouse reveal an essential role for nitric oxide in cytokine-induced bone resorption
45. Impact of antihypertensive therapy on postmenopausal osteoporosis: Effects of the angiotensin converting enzyme inhibitor moexipril, 17beta-estradiol and their combination on the ovariectomy-induced cancellous bone loss in young rats
46. High blood pressure and bone-mineral loss in elderly white women: A prospective study
47. Nitric oxide synthase expression in bone cells
48. Genetic analysis of nitric oxide synthase isoforms: Targeted mutation in mice
49. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate
50. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
51. Increased expression of TGF-b2 in osteoblasts results in an osteoporosis-like phenotype